UK availability guide
Melanotan 2 (MT-2) in the UK: the research peptide explained
MT-2 is among the most searched peptides in the UK — and one of the most misunderstood. This page covers what Melanotan 2 actually is, its legal position in the UK, and why third-party testing matters more for MT-2 than almost any other compound. For laboratory research use only.
Melanocortin research compound
A cyclic alpha-MSH analogue studied at MC1–MC5 receptors in melanogenesis and receptor-signalling research.
Third-party tested
Independent verification of identity and purity on every batch — critical in a market the MHRA has flagged for unregulated products.
Tracked UK delivery
Same-day dispatch before cut-off with tracked delivery in temperature-controlled packaging.
Why quality matters more with MT-2
Melanotan 2 has a long history of grey-market sale through tanning websites and gyms — exactly the products the MHRA has warned about. Those products are sold unlawfully for human use, frequently with no testing behind them, and analyses of seized samples have repeatedly found purity and labelling failures.
The lawful research supply chain looks different: research-use-only labelling, no consumer claims, and independent testing of each finished batch. That is the standard RegenMed operates to — every MT-2 batch is third-party tested with certificates of analysis available on request.
Melanocortin research peptides
MT-2 and the related melanocortin compound PT-141, supplied for laboratory research use with batch-level third-party testing.
Frequently asked questions
What is Melanotan 2 (MT-2)?
What is Melanotan 2 (MT-2)?
Is Melanotan 2 legal in the UK?
Is Melanotan 2 legal in the UK?
What is the difference between Melanotan 1 and Melanotan 2?
What is the difference between Melanotan 1 and Melanotan 2?
Is RegenMed MT-2 third-party tested?
Is RegenMed MT-2 third-party tested?
Related reading
All products sold by RegenMed are supplied strictly for laboratory research purposes only and are not for human consumption. Nothing on this page is medical advice, and no statement has been evaluated by the MHRA or FDA. Content summarising published research is provided for educational purposes.